Article
Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation.
Department of Molecular Microbiology, Box 8230, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110, USA.
Infection and Immunity (impact factor:
4.16).
02/2007;
75(1):52-60.
DOI:10.1128/IAI.01123-06
pp.52-60
Source: PubMed
-
Article: Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli.
[show abstract] [hide abstract]
ABSTRACT: One of the more perplexing aspects of urinary tract infections (UTIs) is their high propensity to recur. It has been proposed that recurrent infections are a result of the reintroduction of bacteria from the gastrointestinal tract (GIT) to the urinary tract (UT); however, since a significant subset of recurrent UTIs are caused by an identical bacterial strain, it has been challenging to formally prove this hypothesis for same-strain recurrences by using epidemiologic approaches. We present data here obtained by using a mouse model of UTIs in which it was shown that 36% (5 of 14) of mice infected with uropathogenic Escherichia coli (UPEC) will have at least one bacteriuric recurrence, with 21% (3 of 14) having more than one recurrence during a 6-week period after an acute UTI. Intraurethrally infected mice develop UPEC reservoirs in both their feces and their bladders. Ten days of trimethoprim-sulfamethoxazole (SXT) therapy reduces urinary recurrences and eradicates fecal colonization, whereas 3 days of SXT treatment has no effect over a twenty-eight-day observation period despite clearing fecal colonization acutely. Interestingly, SXT is unable to eradicate bacteria from the bladder reservoir even after a 10-day treatment regimen, thus demonstrating that the bladder reservoir can persist even in the face of long-term antibiotic therapy.Infection and Immunity 01/2003; 70(12):7042-9. · 4.16 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
asymptomatic bacteriuria
behavior
coinfecting bacteria
different clinical syndromes
distinctive intracellular bacterial communities
form IBCs
IBC cascade
IBC formation
IBC pathway
IBCs
innate host responses
mixed infections
Rapid intracellular replication results
safe haven
subvert clearance
superficial umbrella cells
UPEC strains cultured
uropathogenic Escherichia coli
UTI pathogenesis
well-characterized mouse model